Tumor proliferative fraction solid malignant neoplasms comparative study immunostaining flow cytometric determinations Tumor proliferative fraction TPF prognosis malignancies method determination practical accurate reproducible comparative study techniques TPF values mirror-image samples consecutive solid malignant neoplasms flow cytometry monoclonal antibody unknown nuclear antigen entire cell proliferation cycle cells mean TPF values cases percentage tumor cells range flow cytometry range correlation strong tumors low S-phase values equal tumors intermediate high S-phase values percentages patient age sex tissue origin tumor comparable cytometry determination TPF solid malignancies intermediate high S-phase values tumors low S-phase values immunostaining TPF values increase proportion cells dilutional effect nonneoplastic cells tumors low proliferative fraction 